In Other News

• Ultra-Sensitive DNA Test Identifies Relapse Risk in Aggressive Leukemia

• Protective Brain Protein Emerges as Biomarker Target in Alzheimer’s Disease

• Blood Test Could Help Detect Gallbladder Cancer Earlier

• CRISPR-Based Platform Pinpoints Drivers of Acute Myeloid Leukemia in Patient Cells

• Ultra-Sensitive DNA Test Identifies Relapse Risk in Aggressive Leukemia

• Protective Brain Protein Emerges as Biomarker Target in Alzheimer’s Detection and Therapy

• Molecular Imaging to Reduce Need for Melanoma Biopsies

• New Blood Test Score Detects Hidden Alcohol-Related Liver Disease

• Hidden Gut Viruses Linked to Colorectal Cancer Risk

• New Blood Test Predicts Who Will Most Likely Live Longer

• Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

• Electronic Nose Smells Early Signs of Ovarian Cancer in Blood

• Urine Specimen Collection System Improves Diagnostic Accuracy and Efficiency

• Electronic Nose Smells Early Signs of Ovarian Cancer in Blood

• Genetic Test Predicts Radiation Therapy Risk for Prostate Cancer Patients

• AI-Powered 3D Scanning System Speeds Cancer Screening

• Genetic Test Aids Early Detection and Improved Treatment for Cancers

• New Genome Sequencing Technique Measures Epstein-Barr Virus in Blood

• Blood Test Boosts Early Detection of Brain Cancer

• Blood Test Boosts Early Detection of Brain Cancer

• Changes In Lymphatic Vessels Can Aid Early Identification of Aggressive Oral Cancer

• Molecular Monitoring Approach Helps Bladder Cancer Patients Avoid Surgery

• Three-Test Panel Launched for Detection of Liver Fluke Infections